Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where William M. Switzer is active.

Publication


Featured researches published by William M. Switzer.


The Lancet | 1998

No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts

Walid Heneine; Annika Tibell; William M. Switzer; Paul Sandstrom; Guillermo Vazquez Rosales; Aprille Mathews; Olle Korsgren; Louisa E. Chapman; Thomas M. Folks; Carl G. Groth

BACKGROUND The study of whether porcine xenografts can lead to porcine endogenous retrovirus (PERV) infection of recipients is critical for evaluating the safety of pig-to-man xenotransplantation. PERV is carried in the pig germline, and all recipients of porcine tissues or organs will be exposed to the virus. METHODS We studied 10 diabetic patients who had received porcine fetal islets between 1990 and 1993, looking for evidence of PERV infection by using PCR serology, PCR, and reverse transcriptase assays. Prolonged xenograft survival (up to a year) was confirmed in five patients by porcine C-peptide excretion and detection of pig mitochondrial DNA (mtDNA) in serum. FINDINGS Despite the evidence for extended exposure to pig cells and despite concomitant immunosuppressive therapy, we were unable to detect markers of PERV infection in any patient. Screening for two PERV sequences in peripheral blood lymphocytes collected 4-7 years after the xenotransplantation was negative. Markers of PERV expression, including viral RNA and reverse transcriptase, were undetectable in sera from both early (day 3 to day 180) and late (4-7 years) time points. Western blot analysis for antibodies was consistently negative. INTERPRETATION These results suggested the absence of PERV infection in these patients. Also this study establishes a minimum standard for post-transplant surveillance of patients given porcine xenografts.


Proceedings of the National Academy of Sciences of the United States of America | 2005

Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters.

Nathan D. Wolfe; Walid Heneine; Jean K. Carr; Albert D. Garcia; Vedapuri Shanmugam; Ubald Tamoufe; Judith N. Torimiro; A. Tassy Prosser; Matthew LeBreton; Eitel Mpoudi-Ngole; Francine E. McCutchan; Deborah L. Birx; Thomas M. Folks; Donald S. Burke; William M. Switzer

The human T-lymphotropic viruses (HTLVs) types 1 and 2 originated independently and are related to distinct lineages of simian T-lymphotropic viruses (STLV-1 and STLV-2, respectively). These facts, along with the finding that HTLV-1 diversity appears to have resulted from multiple cross-species transmissions of STLV-1, suggest that contact between humans and infected nonhuman primates (NHPs) may result in HTLV emergence. We investigated the diversity of HTLV among central Africans reporting contact with NHP blood and body fluids through hunting, butchering, and keeping primate pets. We show that this population is infected with a wide variety of HTLVs, including two previously unknown retroviruses: HTLV-4 is a member of a phylogenetic lineage that is distinct from all known HTLVs and STLVs; HTLV-3 falls within the phylogenetic diversity of STLV-3, a group not previously seen in humans. We also document human infection with multiple STLV-1-like viruses. These results demonstrate greater HTLV diversity than previously recognized and suggest that NHP exposure contributes to HTLV emergence. Our discovery of unique and divergent HTLVs has implications for HTLV diagnosis, blood screening, and potential disease development in infected persons. The findings also indicate that cross-species transmission is not the rate-limiting step in pandemic retrovirus emergence and suggest that it may be possible to predict and prevent disease emergence by surveillance of populations exposed to animal reservoirs and interventions to decrease risk factors, such as primate hunting.


The Lancet | 2004

Naturally acquired simian retrovirus infections in central African hunters

Nathan D. Wolfe; William M. Switzer; Jean K. Carr; Vinod Bhullar; Vedapuri Shanmugam; Ubald Tamoufe; A. Tassy Prosser; Judith N. Torimiro; Anthony Wright; Eitel Mpoudi-Ngole; Francine McCutchan; Deborah L. Birx; Thomas M. Folks; Donald S. Burke; Walid Heneine

BACKGROUND Hunting and butchering of wild non-human primates infected with simian immunodeficiency virus (SIV) is thought to have sparked the HIV pandemic. Although SIV and other primate retroviruses infect laboratory workers and zoo workers, zoonotic retrovirus transmission has not been documented in natural settings. We investigated zoonotic infection in individuals living in central Africa. METHODS We obtained behavioural data, plasma samples, and peripheral blood lymphocytes from individuals living in rural villages in Cameroon. We did serological testing, PCR, and sequence analysis to obtain evidence of retrovirus infection. FINDINGS Zoonotic infections with simian foamy virus (SFV), a retrovirus endemic in most Old World primates, were identified in people living in central African forests who reported direct contact with blood and body fluids of wild non-human primates. Ten (1%) of 1099 individuals had antibodies to SFV. Sequence analysis from these individuals revealed three geographically-independent human SFV infections, each of which was acquired from a distinct non-human primate lineage: De Brazzas guenon (Cercopithecus neglectus), mandrill (Mandrillus sphinx), and gorilla (Gorilla gorilla), two of which (De Brazzas guenon and mandrill) are naturally infected with SIV. INTERPRETATION Our findings show that retroviruses are actively crossing into human populations, and demonstrate that people in central Africa are currently infected with SFV. Contact with non-human primates, such as happens during hunting and butchering, can play a part in the emergence of human retroviruses and the reduction of primate bushmeat hunting has the potential to decrease the frequency of disease emergence.


Journal of Virology | 2001

Multiple Groups of Novel Retroviral Genomes in Pigs and Related Species

Clive Patience; William M. Switzer; Yasuhiro Takeuchi; David J. Griffiths; Melanie E. Goward; Walid Heneine; Jonathan P. Stoye; Robin A. Weiss

ABSTRACT In view of the concern over potential infection hazards in the use of porcine tissues and organs for xenotransplantation to humans, we investigated the diversity of porcine endogenous retrovirus (PERV) genomes in the DNA of domestic pigs and related species. In addition to the three known envelope subgroups of infectious gamma retroviruses (PERV-A, -B, and -C), classed together here as PERV group γ1, four novel groups of gamma retrovirus (γ2 to γ5) and four novel groups of beta retrovirus (β1 to β4) genomes were detected in pig DNA using generic and specific PCR primers. PCR quantification indicated that the retroviral genome copy number in the Landrace × Duroc F1 hybrid pig ranged from 2 (β2 and γ5) to approximately 50 (γ1). The γ1, γ2, and β4 genomes were transcribed into RNA in adult kidney tissue. Apart from γ1, the retroviral genomes are not known to be infectious, and sequencing of a small number of amplified genome fragments revealed stop codons in putative open reading frames in several cases. Analysis of DNA from wild boar and other species of Old World pigs (Suidae) and New World peccaries (Tayassuidae) showed that one retrovirus group, β2, was common to all species tested, while the others were present among all Old World species but absent from New World species. The PERV-C subgroup of γ1 genomes segregated among domestic pigs and were absent from two African species (red river hog and warthog). Thus domestic swine and their phylogenetic relatives harbor multiple groups of hitherto undescribed PERV genomes.


Journal of Virology | 2004

Frequent Simian Foamy Virus Infection in Persons Occupationally Exposed to Nonhuman Primates

William M. Switzer; Vinod Bhullar; Vedapuri Shanmugam; Mian Er Cong; Bharat Parekh; Nicholas W. Lerche; Joann L. Yee; John J. Ely; Roumiana S. Boneva; Louisa E. Chapman; Thomas M. Folks; Walid Heneine

ABSTRACT The recognition that AIDS originated as a zoonosis heightens public health concerns associated with human infection by simian retroviruses endemic in nonhuman primates (NHPs). These retroviruses include simian immunodeficiency virus (SIV), simian T-cell lymphotropic virus (STLV), simian type D retrovirus (SRV), and simian foamy virus (SFV). Although occasional infection with SIV, SRV, or SFV in persons occupationally exposed to NHPs has been reported, the characteristics and significance of these zoonotic infections are not fully defined. Surveillance for simian retroviruses at three research centers and two zoos identified no SIV, SRV, or STLV infection in 187 participants. However, 10 of 187 persons (5.3%) tested positive for SFV antibodies by Western blot (WB) analysis. Eight of the 10 were males, and 3 of the 10 worked at zoos. SFV integrase gene (int) and gag sequences were PCR amplified from the peripheral blood lymphocytes available from 9 of the 10 persons. Phylogenetic analysis showed SFV infection originating from chimpanzees (n = 8) and baboons (n = 1). SFV seropositivity for periods of 8 to 26 years (median, 22 years) was documented for six workers for whom archived serum samples were available, demonstrating long-standing SFV infection. All 10 persons reported general good health, and secondary transmission of SFV was not observed in three wives available for WB and PCR testing. Additional phylogenetic analysis of int and gag sequences provided the first direct evidence identifying the source chimpanzees of the SFV infection in two workers. This study documents more frequent infection with SFV than with other simian retroviruses in persons working with NHPs and provides important information on the natural history and species origin of these infections. Our data highlight the importance of studies to better define the public health implications of zoonotic SFV infections.


Retrovirology | 2010

Absence of evidence of Xenotropic Murine Leukemia Virus-related virus infection in persons with Chronic Fatigue Syndrome and healthy controls in the United States

William M. Switzer; Hongwei Jia; Oliver Hohn; HaoQiang Zheng; Anupama Shankar; Norbert Bannert; Graham Simmons; R. Michael Hendry; Virginia R. Falkenberg; William C. Reeves; Walid Heneine

BackgroundXMRV, a xenotropic murine leukemia virus (MuLV)-related virus, was recently identified by PCR testing in 67% of persons with chronic fatigue syndrome (CFS) and in 3.7% of healthy persons from the United States. To investigate the association of XMRV with CFS we tested blood specimens from 51 persons with CFS and 56 healthy persons from the US for evidence of XMRV infection by using serologic and molecular assays. Blinded PCR and serologic testing were performed at the US Centers for Disease Control and Prevention (CDC) and at two additional laboratories.ResultsArchived blood specimens were tested from persons with CFS defined by the 1994 international research case definition and matched healthy controls from Wichita, Kansas and metropolitan, urban, and rural Georgia populations. Serologic testing at CDC utilized a Western blot (WB) assay that showed excellent sensitivity to MuLV and XMRV polyclonal or monoclonal antibodies, and no reactivity on sera from 121 US blood donors or 26 HTLV-and HIV-infected sera. Plasma from 51 CFS cases and plasma from 53 controls were all WB negative. Additional blinded screening of the 51 cases and 53 controls at the Robert Koch Institute using an ELISA employing recombinant Gag and Env XMRV proteins identified weak seroreactivity in one CFS case and a healthy control, which was not confirmed by immunofluorescence. PCR testing at CDC employed a gag and a pol nested PCR assay with a detection threshold of 10 copies in 1 ug of human DNA. DNA specimens from 50 CFS patients and 56 controls and 41 US blood donors were all PCR-negative. Blinded testing by a second nested gag PCR assay at the Blood Systems Research Institute was also negative for DNA specimens from the 50 CFS cases and 56 controls.ConclusionsWe did not find any evidence of infection with XMRV in our U.S. study population of CFS patients or healthy controls by using multiple molecular and serologic assays. These data do not support an association of XMRV with CFS.


PLOS Pathogens | 2008

Molecular ecology and natural history of Simian foamy virus infection in wild-living chimpanzees

Weimin Liu; Michael Worobey; Yingying Li; Brandon F. Keele; Frederic Bibollet-Ruche; Yuanyuan Guo; Paul A. Goepfert; Mario L. Santiago; Jean Bosco N Ndjango; Cecile Neel; Stephen L. Clifford; Crickette M. Sanz; Shadrack Kamenya; Michael L. Wilson; Anne E. Pusey; Nicole Gross-Camp; Christophe Boesch; Vince Smith; Koichiro Zamma; Michael A. Huffman; John C. Mitani; David P. Watts; Martine Peeters; George M. Shaw; William M. Switzer; Paul M. Sharp; Beatrice H. Hahn

Identifying microbial pathogens with zoonotic potential in wild-living primates can be important to human health, as evidenced by human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2) and Ebola virus. Simian foamy viruses (SFVs) are ancient retroviruses that infect Old and New World monkeys and apes. Although not known to cause disease, these viruses are of public health interest because they have the potential to infect humans and thus provide a more general indication of zoonotic exposure risks. Surprisingly, no information exists concerning the prevalence, geographic distribution, and genetic diversity of SFVs in wild-living monkeys and apes. Here, we report the first comprehensive survey of SFVcpz infection in free-ranging chimpanzees (Pan troglodytes) using newly developed, fecal-based assays. Chimpanzee fecal samples (n = 724) were collected at 25 field sites throughout equatorial Africa and tested for SFVcpz-specific antibodies (n = 706) or viral nucleic acids (n = 392). SFVcpz infection was documented at all field sites, with prevalence rates ranging from 44% to 100%. In two habituated communities, adult chimpanzees had significantly higher SFVcpz infection rates than infants and juveniles, indicating predominantly horizontal rather than vertical transmission routes. Some chimpanzees were co-infected with simian immunodeficiency virus (SIVcpz); however, there was no evidence that SFVcpz and SIVcpz were epidemiologically linked. SFVcpz nucleic acids were recovered from 177 fecal samples, all of which contained SFVcpz RNA and not DNA. Phylogenetic analysis of partial gag (616 bp), pol-RT (717 bp), and pol-IN (425 bp) sequences identified a diverse group of viruses, which could be subdivided into four distinct SFVcpz lineages according to their chimpanzee subspecies of origin. Within these lineages, there was evidence of frequent superinfection and viral recombination. One chimpanzee was infected by a foamy virus from a Cercopithecus monkey species, indicating cross-species transmission of SFVs in the wild. These data indicate that SFVcpz (i) is widely distributed among all chimpanzee subspecies; (ii) is shed in fecal samples as viral RNA; (iii) is transmitted predominantly by horizontal routes; (iv) is prone to superinfection and recombination; (v) has co-evolved with its natural host; and (vi) represents a sensitive marker of population structure that may be useful for chimpanzee taxonomy and conservation strategies.


Journal of Acquired Immune Deficiency Syndromes | 1996

Male-to-female transmission of human T-cell lymphotropic virus types I and II : Association with viral load

Jonathan E. Kaplan; Rima F. Khabbaz; Edward L. Murphy; Sigurd Hermansen; Chester R. Roberts; Renu B. Lal; Walid Heneine; David Wright; Lauri Matijas; Ruth A. Thomson; Donna L. Rudolph; William M. Switzer; Steven H. Kleinman; Michael P. Busch; George B. Schreiber

SUMMARY Risk factors for male-to-female sexual transmission of human T-lymphotropic virus types I and II (HTLV-I/II) were investigated among HTLV-seropositive volunteer blood donors and their long-term (> or = 6 month) sex partners. Direction of transmission in concordantly seropositive pairs was assessed by analyzing risk factors for HTLV infection. Donors and their partners were also questioned regarding sexual behaviors during their relationships; HTLV antibody titers and viral load were determined for specimens from male partners. Among 31 couples in whom HTLV-infected men likely transmitted infection to their partners (11 HTLV-I and 20 HTLV-II) and 25 male-positive, female-negative couples (8 HTLV-I and 17 HTLV-II), HTLV transmitter men had been in their relationships longer (mean 225 months vs. 122 months) and had higher viral loads (geometric mean 257,549 vs. 2,945 copies/300,000 cells for HTLV-I; 5,541 vs. 118 copies/300,000 cells for HTLV-II) than non-transmitters (P = 0.018 and P = 0.001 for duration of relationship and viral load, respectively, logistic regression analysis). Transmitter men also tended to have higher antibody titers against various env and whole virus proteins than non-transmitters. The identification of high viral load and duration of relationship as risk factors provides a biologically plausible framework in which to assess risk of sexual transmission of the HTLVs.


Journal of Medical Virology | 2000

Human immunodeficiency virus type 2 (HIV‐2) in Portugal: Clinical spectrum, circulating subtypes, virus isolation, and plasma viral load

Vincent Soriano; Perpétua Gomes; Walid Heneine; África Holguín; Manuela Doruana; Rute Antunes; Kamal Mansinho; William M. Switzer; Carlos Araújo; Vedapuri Shanmugam; Helena Ramalhinho Dias Lourenço; Juan González-Lahoz; Francisco Antunes

The human immunodeficiency virus type 2 (HIV‐2) is responsible for 4.5% of AIDS cases in Portugal. Six HIV‐2 subtypes have been described so far, subtype A being proposed as more pathogenic than the rest. The relationship between the clinical status and levels of both cellular and plasma HIV‐2 viraemia is not well known, nor their modifications under antiretroviral therapy. Thirty‐two consecutive HIV‐2 infected persons (17 men, 15 women) attending two different hospitals in Lisbon in 1997 were enrolled prospectively in the study. All but 4 individuals most likely acquired the infection through heterosexual contact. More than half of the study population was of African origin, mainly from Guinea‐Bissau. Eleven (34.4%) patients had developed clinical manifestations included within the B or C groups of the CDC classification system for HIV infection, with the rest being asymptomatic. Half of the population was undergoing antiretroviral treatment at the time of the study. HIV‐2 subtypes were investigated using a new Nef‐based restriction fragment length polymorphism (RFLP) method that allows differentiation of the main two variants, A and B. Plasma viral load was quantified using a new quantitative competitive reverse transcriptase polymerase chain reaction (QcRT‐PCR) procedure as well as the Amp‐RT assay. Virus isolation was attempted from peripheral blood mononuclear cells. All but one person carried HIV‐2 subtype A. Plasma viraemia examined by QcRT‐PCR was measurable in 15 (50%) of 30 subjects, yielding in all instances values below 20,000 HIV‐2 RNA copies per ml. Plasma RT activity could be detected in only 10 (33%) of 30 subjects, a rate much lower than that seen in HIV‐1 infection. Virus was isolated from 16 (53.3%) of 30 patients. A significant correlation was found between CD4+ counts, clinical status, rate of virus isolation, and plasma viral load by both QcRT‐PCR and Amp‐RT. In conclusion, HIV‐2 subtype A is the predominant variant circulating in Portugal among both natives and immigrants. A lower cellular and plasma viral load with respect to HIV‐1 was seen in persons without immunosuppression, from whom the rate of virus recovery was extremely low. J. Med. Virol. 61:111–116, 2000.


Emerging Infectious Diseases | 2006

Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa.

Zhiquan Xiang; Yan Li; Ann Cun; Wei Yang; Susan S. Ellenberg; William M. Switzer; Marcia L. Kalish; Hildegund C.J. Ertl

Human sera from the United States, Thailand, and sub-Saharan Africa and chimpanzee sera were tested for neutralizing antibodies to 3 chimpanzee adenoviruses. Antibodies were more common in humans residing in sub-Saharan Africa than in humans living in the United States or Thailand. This finding suggests cross-species transmission of chimpanzee adenoviruses.

Collaboration


Dive into the William M. Switzer's collaboration.

Top Co-Authors

Avatar

Walid Heneine

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Thomas M. Folks

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Anupama Shankar

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Hongwei Jia

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Vedapuri Shanmugam

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

HaoQiang Zheng

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Paul Sandstrom

Public Health Agency of Canada

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Graham Simmons

University of California

View shared research outputs
Top Co-Authors

Avatar

Louisa E. Chapman

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge